These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22009194)

  • 61. Attenuated Mismatch Negativity in Attenuated Psychosis Syndrome Predicts Psychosis: Can Galantamine-Memantine Combination Prevent Psychosis?
    Koola MM
    Mol Neuropsychiatry; 2018 Oct; 4(2):71-74. PubMed ID: 30397594
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alcohol Triggers Reemergence of Ketamine-Like Experience in a Ketamine Ex-User.
    Chang F; Xu K; Huang MC; Krystal JH
    J Clin Psychopharmacol; 2017 Feb; 37(1):110-112. PubMed ID: 28027112
    [No Abstract]   [Full Text] [Related]  

  • 63. Forecasting psychosis by event-related potentials-systematic review and specific meta-analysis.
    Bodatsch M; Brockhaus-Dumke A; Klosterkötter J; Ruhrmann S
    Biol Psychiatry; 2015 Jun; 77(11):951-8. PubMed ID: 25636178
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Progressive Impairment of Mismatch Negativity Is Reflective of Underlying Pathophysiological Changes in Patients With First-Episode Psychosis.
    Lho SK; Kim M; Park J; Hwang WJ; Moon SY; Oh S; Kwon JS
    Front Psychiatry; 2020; 11():587. PubMed ID: 32625126
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neurophysiological alterations in the prepsychotic phases.
    Crossley NA; Constante M; Fusar-Poli P; Bramon E
    Curr Pharm Des; 2012; 18(4):479-85. PubMed ID: 22239578
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neurophysiology for Detection of High Risk for Psychosis.
    Pantlin LN; Davalos D
    Schizophr Res Treatment; 2016; 2016():2697971. PubMed ID: 27579180
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Healthcare Utilisation, Morbidities and Alcohol Use Monitoring Prior to Alcoholic Psychosis Diagnosis.
    Otete H; Fleming MK; West J; Orton E
    Alcohol Alcohol; 2019 Mar; 54(2):131-138. PubMed ID: 30576413
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia.
    Light GA; Swerdlow NR
    Ann N Y Acad Sci; 2015 May; 1344(1):105-19. PubMed ID: 25752648
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The diagnosis of pathological intoxication.
    Maletzky BM
    J Stud Alcohol; 1976 Sep; 37(9):1215-28. PubMed ID: 979273
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Can N‑acetylcysteine, varenicline, or the combination prevent psychosis by enhancing mismatch negativity?
    Koola MM
    Schizophr Res; 2019 Apr; 206():452-453. PubMed ID: 30473210
    [No Abstract]   [Full Text] [Related]  

  • 71. Clinical classification in mental health at the cross-roads: which direction next?
    Hickie IB; Scott J; Hermens DF; Scott EM; Naismith SL; Guastella AJ; Glozier N; McGorry PD
    BMC Med; 2013 May; 11():125. PubMed ID: 23672522
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Delayed preattentional functioning in early psychosis patients with cannabis use.
    Pesa N; Hermens DF; Battisti RA; Kaur M; Hickie IB; Solowij N
    Psychopharmacology (Berl); 2012 Aug; 222(3):507-18. PubMed ID: 22402706
    [TBL] [Abstract][Full Text] [Related]  

  • 73. MMN/P3a deficits in first episode psychosis: comparing schizophrenia-spectrum and affective-spectrum subgroups.
    Kaur M; Battisti RA; Ward PB; Ahmed A; Hickie IB; Hermens DF
    Schizophr Res; 2011 Aug; 130(1-3):203-9. PubMed ID: 21550211
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mismatch negativity (MMN) deficiency: a break-through biomarker in predicting psychosis onset.
    Näätänen R; Shiga T; Asano S; Yabe H
    Int J Psychophysiol; 2015 Mar; 95(3):338-44. PubMed ID: 25562834
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alcohol use and mismatch negativity in young patients with psychotic disorder.
    Chitty KM; Kaur M; Lagopoulos J; Hickie IB; Hermens DF
    Neuroreport; 2011 Dec; 22(17):918-22. PubMed ID: 22009194
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Impaired MMN/P3a complex in first-episode psychosis: cognitive and psychosocial associations.
    Hermens DF; Ward PB; Hodge MA; Kaur M; Naismith SL; Hickie IB
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):822-9. PubMed ID: 20302901
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders.
    Kaur M; Lagopoulos J; Lee RS; Ward PB; Naismith SL; Hickie IB; Hermens DF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():161-9. PubMed ID: 23851120
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.